What does Innovestor Life Science invest in?
Innovestor Life Science invests most often at Series A and Series B (100% of the rounds on record).
Last cheque observed Oct 2026; 2 cheques on record.
Deploying nowVC firm
2 cheques in the last 12 months
Mostly Series A and Series B: 100% of its rounds
Every round we can evidence, newest first2 appearances
2 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The investors most often in the same rounds as Innovestor Life Science. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Innovestor Life Science put money into.
Innovestor Life Science invests most often at Series A and Series B (100% of the rounds on record).
2 investments on record, 2 of them in the last 12 months. The most recent was in Oct 2026.
Its most recent investments on record: AnaCardio (Series B, Oct 2026) and Breye Therapeutics (Series A, Sept 2026).
The median round it joins is $74M.
Yes: it is actively investing, with 2 investments in the last 12 months.
Most often Innovestor (2 rounds together), Ljungström family office (2 rounds together) and Novo Holdings (2 rounds together).
Innovestor Life Science is a VC firm.
From 5 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it